Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation.

Trial Profile

Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Fludarabine (Primary)
  • Indications Leukaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 Apr 2015 Status changed from recruiting to active, no longer recruiting as per results presented at the 56th Annual Meeting and Exposition of the American Society of Hematology.
    • 18 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top